References
- Noone D, Skouw-Rasmussen N, Lavin M, van Galen KPM, Kadir RA. Barriers and challenges faced by women with congenital bleeding disorders in Europe: Results of a patient survey conducted by the European Haemophilia Consortium. Haemophilia 2019; 25(3): 468-74. doi: 10.1111/hae.13722.
- World Federation of Hemophilia. WFH Annual Report 2017. Available from http://www1.wfh.org/publications/files/pdf-1696.pdf (accessed 29 May 2019).
- Jacobson AE, Vesely SK, Koch T, Campbell K, O’Brien SH. Patterns of von Willebrand disease screening in girls and adolescents with heavy menstrual bleeding. Obstet Gynecol 2018; 131: 1121-29. doi: 10.1097/ AOG.0000000000002620.
- Lavin M, Aguila S, Dalton N, et al Significant gynecological bleeding in women with low von Willebrand factor levels. Blood Adv 2018; 2: 1784-91. doi: 10.1182/ bloodadvances.2018017418.
- Committee on Adolescent Health Care, Committee on Gynecologic Practice, American College of Obstetrics and Gynecology. Committee Opinion No. 580: von Willebrand disease in women. Obstet Gynecol 2013; 122: 1368-73. doi: 10.1097/01.AOG.0000438961.38979.19.